Temat: "Urinary Bladder Neoplasms" - OpacWWW

Skocz do pozycji: 1.

Tytuł:: Efficacy and safety of dose-dense gemcitabine plus cisplatin as neoadjuvant chemotherapy for muscle-invasive bladder cancer.
Autorzy:: Hattori Y; Department of Urology, Kobe City Medical Centre General Hospital, Kobe, Japan.
Fujiwara T; Department of Urology, Kobe City Medical Centre General Hospital, Kobe, Japan.
Hagimoto H; Department of Urology, Kobe City Medical Centre General Hospital, Kobe, Japan.
Kokubun H; Department of Urology, Kobe City Medical Centre General Hospital, Kobe, Japan.
Murata S; Department of Urology, Kobe City Medical Centre General Hospital, Kobe, Japan.
Makita N; Department of Urology, Kobe City Medical Centre General Hospital, Kobe, Japan.
Abe Y; Department of Urology, Kobe City Medical Centre General Hospital, Kobe, Japan.
Kubota M; Department of Urology, Kobe City Medical Centre General Hospital, Kobe, Japan.
Tohi Y; Department of Urology, Kobe City Medical Centre General Hospital, Kobe, Japan.
Tsutsumi N; Department of Urology, Kobe City Medical Centre General Hospital, Kobe, Japan.
Shibasaki N; Department of Urology, Kobe City Medical Centre General Hospital, Kobe, Japan.
Inoue K; Department of Urology, Kobe City Medical Centre General Hospital, Kobe, Japan.
Kawakita M; Department of Urology, Kobe City Medical Centre General Hospital, Kobe, Japan.
Yamasaki T; Department of Urology, Kobe City Medical Centre General Hospital, Kobe, Japan.; Pokaż więcej
Źródło:: International journal of urology : official journal of the Japanese Urological Association [Int J Urol] 2024 Oct; Vol. 31 (10), pp. 1102-1106. Date of Electronic Publication: 2024 Jul 03.
Typ publikacji:: Journal Article
MeSH Terms:: Urinary Bladder Neoplasms*/drug therapy
Urinary Bladder Neoplasms*/pathology
Urinary Bladder Neoplasms*/surgery
Urinary Bladder Neoplasms*/mortality
Gemcitabine*
Deoxycytidine*/analogs & derivatives
Deoxycytidine*/administration & dosage
Deoxycytidine*/adverse effects
Cisplatin*/administration & dosage
Cisplatin*/adverse effects
Neoadjuvant Therapy*/methods
Neoadjuvant Therapy*/adverse effects
Antineoplastic Combined Chemotherapy Protocols*/adverse effects
Antineoplastic Combined Chemotherapy Protocols*/therapeutic use
Antineoplastic Combined Chemotherapy Protocols*/administration & dosage
Cystectomy*
Neoplasm Invasiveness*
Humans ; Male ; Female ; Aged ; Middle Aged ; Retrospective Studies ; Treatment Outcome ; Disease-Free Survival ; Chemotherapy, Adjuvant/methods ; Chemotherapy, Adjuvant/adverse effects ; Filgrastim/administration & dosage ; Filgrastim/adverse effects ; Adult ; Polyethylene Glycols

Czasopismo naukowe

na półce

Full Text Finder Szczegóły

Skocz do pozycji: 2.

Tytuł:: Longitudinal Tumor-informed Circulating Tumor DNA Status Predicts Disease Upstaging and Poor Prognosis for Patients Undergoing Radical Cystectomy.
Autorzy:: Ben-David R; Urology Department, Icahn School of Medicine at Mount Sinai, New York, NY, USA. Electronic address: .
Tillu N; Urology Department, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
Cumarasamy S; Urology Department, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
Alerasool P; The Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
Rich JM; Urology Department, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
Kaufmann B; Urology Department, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
Elkun Y; Urology Department, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
Attalla K; Urology Department, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
Mehrazin R; Urology Department, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
Wiklund P; Urology Department, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
Sfakianos JP; Urology Department, Icahn School of Medicine at Mount Sinai, New York, NY, USA.; Pokaż więcej
Źródło:: European urology oncology [Eur Urol Oncol] 2024 Oct; Vol. 7 (5), pp. 1105-1112. Date of Electronic Publication: 2024 Mar 22.
Typ publikacji:: Journal Article
MeSH Terms:: Cystectomy*/methods
Urinary Bladder Neoplasms*/surgery
Urinary Bladder Neoplasms*/blood
Urinary Bladder Neoplasms*/pathology
Urinary Bladder Neoplasms*/genetics
Circulating Tumor DNA*/blood
Neoplasm Staging*
Humans ; Male ; Female ; Aged ; Prognosis ; Middle Aged ; Prospective Studies

Czasopismo naukowe

na półce

Full Text Finder Szczegóły

Skocz do pozycji: 3.

Tytuł:: Assessing muscle invasion in bladder cancer via virtual biopsy: a study on quantitative parameters and classical radiomics features from dual-energy CT imaging.
Autorzy:: Hu M; Department of Radiology, First Affiliated Hospital of Dalian Medical University, No.193, Lianhe Road, Xigang District, Dalian, China.
Wei W; Department of Radiology, First Affiliated Hospital of Dalian Medical University, No.193, Lianhe Road, Xigang District, Dalian, China.
Zhang J; Department of Radiology, First Affiliated Hospital of Dalian Medical University, No.193, Lianhe Road, Xigang District, Dalian, China.
Wang S; Department of Radiology, First Affiliated Hospital of Dalian Medical University, No.193, Lianhe Road, Xigang District, Dalian, China.
Tong X; Department of Radiology, First Affiliated Hospital of Dalian Medical University, No.193, Lianhe Road, Xigang District, Dalian, China.
Fan Y; Department of Radiology, First Affiliated Hospital of Dalian Medical University, No.193, Lianhe Road, Xigang District, Dalian, China.
Cheng Q; Department of Radiology, First Affiliated Hospital of Dalian Medical University, No.193, Lianhe Road, Xigang District, Dalian, China.
Liu Y; Department of Radiology, First Affiliated Hospital of Dalian Medical University, No.193, Lianhe Road, Xigang District, Dalian, China.
Li J; CT Research, GE Healthcare, Dalian, China.
Liu L; Department of Urology, First Affiliated Hospital of Dalian Medical University, Dalian, China. .; Pokaż więcej
Źródło:: BMC medical imaging [BMC Med Imaging] 2024 Sep 16; Vol. 24 (1), pp. 245. Date of Electronic Publication: 2024 Sep 16.
Typ publikacji:: Journal Article
MeSH Terms:: Urinary Bladder Neoplasms*/diagnostic imaging
Urinary Bladder Neoplasms*/pathology
Tomography, X-Ray Computed*/methods
Neoplasm Invasiveness*/diagnostic imaging
Humans ; Male ; Female ; Retrospective Studies ; Aged ; Middle Aged ; Biopsy ; Aged, 80 and over ; Radiography, Dual-Energy Scanned Projection/methods ; ROC Curve ; Adult ; Radiomics

Czasopismo naukowe

na półce

Full Text Finder Szczegóły

Skocz do pozycji: 4.

Tytuł:: Immunophenotypic and molecular changes during progression of papillary urothelial carcinoma.
Autorzy:: Kim B; Department of Pathology, Konkuk University Medical Center, Konkuk University School of Medicine, Seoul, Korea.
Kim K; Transdisciplinary Department of Medicine & Advanced Technology, Seoul National University Hospital, Seoul, Korea.
Yang S; Transdisciplinary Department of Medicine & Advanced Technology, Seoul National University Hospital, Seoul, Korea.
Moon KC; Department of Pathology, Seoul National University College of Medicine, Seoul, Korea.; Department of Pathology, Seoul National University Hospital, Seoul, Korea.; Kidney Research Institute, Medical Research Center, Seoul National University College of Medicine, Seoul, Korea. .; Pokaż więcej
Źródło:: Investigative and clinical urology [Investig Clin Urol] 2024 Sep; Vol. 65 (5), pp. 501-510.
Typ publikacji:: Journal Article
MeSH Terms:: Urinary Bladder Neoplasms*/genetics
Urinary Bladder Neoplasms*/pathology
Disease Progression*
Carcinoma, Papillary*/pathology
Carcinoma, Papillary*/genetics
Carcinoma, Transitional Cell*/genetics
Carcinoma, Transitional Cell*/pathology
Humans ; Male ; Female ; Aged ; Middle Aged ; Immunophenotyping ; Neoplasm Invasiveness ; Keratin-20/genetics ; Immunohistochemistry ; Aged, 80 and over

Czasopismo naukowe

na półce

Pełny tekst Szczegóły

Skocz do pozycji: 5.

Tytuł:: Incidence and management of prostatic urethra recurrence in a cohort of 21 patients who received BCG induction for non-muscle invasive bladder cancer.
Autorzy:: Ingram JW; Department of Urology, Columbia University Medical Center, New York, NY.
Chung R; Department of Urology, Columbia University Medical Center, New York, NY.
Laplaca C; Department of Urology, Columbia University Medical Center, New York, NY.
McKiernan JM; Department of Urology, Columbia University Medical Center, New York, NY.
Lenis AT; Department of Urology, Columbia University Medical Center, New York, NY.
Anderson CB; Department of Urology, Columbia University Medical Center, New York, NY. Electronic address: .; Pokaż więcej
Źródło:: Urologic oncology [Urol Oncol] 2024 Sep; Vol. 42 (9), pp. 290.e11-290.e16. Date of Electronic Publication: 2024 Apr 29.
Typ publikacji:: Journal Article
MeSH Terms:: Urinary Bladder Neoplasms*/pathology
Urinary Bladder Neoplasms*/therapy
BCG Vaccine*/therapeutic use
BCG Vaccine*/administration & dosage
Neoplasm Recurrence, Local*
Humans ; Male ; Retrospective Studies ; Aged ; Middle Aged ; Incidence ; Prostatic Neoplasms/pathology ; Prostatic Neoplasms/therapy ; Neoplasm Invasiveness ; Cohort Studies ; Urethral Neoplasms/therapy ; Urethral Neoplasms/pathology ; Adjuvants, Immunologic/therapeutic use ; Aged, 80 and over ; Carcinoma, Transitional Cell/therapy ; Carcinoma, Transitional Cell/pathology ; Non-Muscle Invasive Bladder Neoplasms

Czasopismo naukowe

na półce

Full Text Finder Szczegóły

Skocz do pozycji: 6.

Tytuł:: Transurethral enucleation of bladder tumor containing non-functional paraganglioma: A case report.
Autorzy:: Song HC; Department of Urology, Beijing Friendship Hospital, Capital Medical University, Beijing, China. Electronic address: .
Liu JX; Department of Urology, Beijing Friendship Hospital, Capital Medical University, Beijing, China; Department of Urology, Beijing Fuxing Hospital, Capital Medical University, Beijing, China. Electronic address: .
Song J; Department of Urology, Beijing Friendship Hospital, Capital Medical University, Beijing, China. Electronic address: .
Li XH; Department of Urology, Beijing Friendship Hospital, Capital Medical University, Beijing, China. Electronic address: .; Pokaż więcej
Źródło:: Asian journal of surgery [Asian J Surg] 2024 Sep; Vol. 47 (9), pp. 4222-4223. Date of Electronic Publication: 2024 May 25.
Typ publikacji:: Case Reports; Letter
MeSH Terms:: Urinary Bladder Neoplasms*/surgery
Urinary Bladder Neoplasms*/pathology
Paraganglioma*/surgery
Paraganglioma*/diagnostic imaging
Paraganglioma*/pathology
Humans ; Male ; Urethra/surgery ; Treatment Outcome ; Middle Aged

Raport

na półce

Full Text Finder Szczegóły

Skocz do pozycji: 7.

Tytuł:: Immune checkpoint gene signature assesses immune infiltration profiles in bladder cancer and identifies KRT23 as an immunotherapeutic target.
Autorzy:: Chen D; Department of Urology, Beijing Chaoyang Hospital Affiliated Capital Medical University, 8 Gong Ti Nan Road, Chaoyang District, Beijing, 100020, China.; Department of Urology, Qilu Hospital of Shandong University, Wenhuaxi Road #107, Jinan, 250012, China.
Cao H; Department of Urology, Beijing Chaoyang Hospital Affiliated Capital Medical University, 8 Gong Ti Nan Road, Chaoyang District, Beijing, 100020, China.
Zheng X; Department of Urology, Beijing Chaoyang Hospital Affiliated Capital Medical University, 8 Gong Ti Nan Road, Chaoyang District, Beijing, 100020, China.
Wang H; Department of Urology, Beijing Chaoyang Hospital Affiliated Capital Medical University, 8 Gong Ti Nan Road, Chaoyang District, Beijing, 100020, China.
Han Z; Department of Urology, The Second Affiliated Hospital of Shandong University of Traditional Chinese Medicine, NO.1 Jingba Road, Shizhong District, Jinan, 250001, China. .
Wang W; Department of Urology, Beijing Chaoyang Hospital Affiliated Capital Medical University, 8 Gong Ti Nan Road, Chaoyang District, Beijing, 100020, China. .; Pokaż więcej
Źródło:: BMC cancer [BMC Cancer] 2024 Aug 19; Vol. 24 (1), pp. 1024. Date of Electronic Publication: 2024 Aug 19.
Typ publikacji:: Journal Article
MeSH Terms:: Tumor Microenvironment*/immunology
Tumor Microenvironment*/genetics
Urinary Bladder Neoplasms*/genetics
Urinary Bladder Neoplasms*/immunology
Urinary Bladder Neoplasms*/therapy
Urinary Bladder Neoplasms*/drug therapy
Urinary Bladder Neoplasms*/pathology
Aged ; Female ; Humans ; Male ; Middle Aged ; Biomarkers, Tumor/genetics ; Gene Expression Profiling ; Gene Expression Regulation, Neoplastic ; Immune Checkpoint Inhibitors/therapeutic use ; Immune Checkpoint Proteins/genetics ; Immune Checkpoint Proteins/metabolism ; Immunotherapy/methods ; Lymphocytes, Tumor-Infiltrating/immunology ; Lymphocytes, Tumor-Infiltrating/metabolism ; Prognosis ; Transcriptome ; Keratins, Type I/genetics ; Keratins, Type I/metabolism

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 8.

Tytuł:: Glutathione-S-Transferase Theta 2 (GSTT2) Modulates the Response to Bacillus Calmette-Guérin Immunotherapy in Bladder Cancer Patients.
Autorzy:: Rahmat JN; Department of Surgery, Yong Loo Lin School of Medicine, National University of Singapore, Singapore 119228, Singapore.
Tham SM; Department of Surgery, Yong Loo Lin School of Medicine, National University of Singapore, Singapore 119228, Singapore.
Ong TL; School of Engineering, Biomedical Engineering, Temasek Polytechnic, Singapore 529757, Singapore.
Lim YK; Department of Surgery, Yong Loo Lin School of Medicine, National University of Singapore, Singapore 119228, Singapore.
Patwardhan MV; Department of Surgery, Yong Loo Lin School of Medicine, National University of Singapore, Singapore 119228, Singapore.
Nee Mani LR; Department of Surgery, Yong Loo Lin School of Medicine, National University of Singapore, Singapore 119228, Singapore.
Kamaraj R; Department of Surgery, Yong Loo Lin School of Medicine, National University of Singapore, Singapore 119228, Singapore.
Chan YH; Biostatistics Unit, Yong Loo Lin School of Medicine, National University of Singapore, Singapore 117597, Singapore.
Chong TW; Department of Urology, Singapore General Hospital, Singapore 169608, Singapore.; Division of Surgery & Surgical Oncology, National Cancer Center Singapore, Singapore 168583, Singapore.
Chiong E; Department of Surgery, Yong Loo Lin School of Medicine, National University of Singapore, Singapore 119228, Singapore.; Department of Urology, National University Hospital, National University Health System, Singapore 119074, Singapore.
Esuvaranathan K; Department of Surgery, Yong Loo Lin School of Medicine, National University of Singapore, Singapore 119228, Singapore.; Department of Urology, National University Hospital, National University Health System, Singapore 119074, Singapore.
Mahendran R; Department of Surgery, Yong Loo Lin School of Medicine, National University of Singapore, Singapore 119228, Singapore.; Pokaż więcej
Źródło:: International journal of molecular sciences [Int J Mol Sci] 2024 Aug 16; Vol. 25 (16). Date of Electronic Publication: 2024 Aug 16.
Typ publikacji:: Journal Article
MeSH Terms:: Urinary Bladder Neoplasms*/genetics
Urinary Bladder Neoplasms*/therapy
Urinary Bladder Neoplasms*/drug therapy
Urinary Bladder Neoplasms*/immunology
Glutathione Transferase*/genetics
Glutathione Transferase*/metabolism
BCG Vaccine*/therapeutic use
Immunotherapy*/methods
Humans ; Animals ; Mice ; Female ; Male ; Aged ; Middle Aged ; Polymorphism, Single Nucleotide ; Cell Line, Tumor ; Dendritic Cells/immunology ; Dendritic Cells/metabolism ; Mice, Knockout ; Mycobacterium bovis

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 9.

Tytuł:: Pictorial review of multiparametric MRI in bladder urothelial carcinoma with variant histology: pearls and pitfalls.
Autorzy:: Arita Y; Department of Radiology, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, NY, 10065, USA. .
Woo S; Department of Radiology, NYU Langone Health, New York, USA.
Kwee TC; Department of Radiology, Nuclear Medicine and Molecular Imaging, University Medical Center Groningen, Groningen, Netherlands.
Shigeta K; Department of Urology, Keio University School of Medicine, Tokyo, Japan.
Ueda R; Office of Radiation Technology, Keio University Hospital, Tokyo, Japan.
Nalavenkata S; Department of Urology, Memorial Sloan Kettering Cancer Center, New York, USA.
Edo H; Department of Radiology, National Defense Medical Collage, Saitama, Japan.
Miyai K; Department of Pathology and Laboratory Medicine, National Defense Medical College, Saitama, Japan.
Das J; Department of Radiology, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, NY, 10065, USA.
Andrieu PIC; Department of Radiology, Mayo Clinic, Rochester, USA.
Vargas HA; Department of Radiology, NYU Langone Health, New York, USA.; Pokaż więcej
Źródło:: Abdominal radiology (New York) [Abdom Radiol (NY)] 2024 Aug; Vol. 49 (8), pp. 2797-2811. Date of Electronic Publication: 2024 Jun 07.
Typ publikacji:: Journal Article; Review
MeSH Terms:: Urinary Bladder Neoplasms*/diagnostic imaging
Urinary Bladder Neoplasms*/pathology
Multiparametric Magnetic Resonance Imaging*/methods
Carcinoma, Transitional Cell*/diagnostic imaging
Carcinoma, Transitional Cell*/pathology
Humans ; Contrast Media ; Neoplasm Invasiveness ; Diagnosis, Differential ; Urinary Bladder/diagnostic imaging ; Urinary Bladder/pathology

Czasopismo naukowe

na półce

Full Text Finder Szczegóły

Skocz do pozycji: 10.

Tytuł:: ARNTL2 facilitates bladder cancer progression through potentiating ENO1-mediated glycolysis in a SLC31A1-independent and -dependent manner.
Autorzy:: Wang J; Department of Urology/Institute of Urology, West China Hospital, Sichuan University, Chengdu, Sichuan, China.
Ren J; Department of Urology/Institute of Urology, West China Hospital, Sichuan University, Chengdu, Sichuan, China.
Tu X; Department of Urology/Institute of Urology, West China Hospital, Sichuan University, Chengdu, Sichuan, China.
Yuan H; Department of Urology, Peking University Shenzhen Hospital, Shenzhen, Guangdong, China.
Ye Z; Department of Urology, West China Xiamen Hospital of Sichuan University, Xiamen, Fujian, China.
Wang X; Department of Urology/Institute of Urology, West China Hospital, Sichuan University, Chengdu, Sichuan, China.
Cui J; Department of Urology/Institute of Urology, West China Hospital, Sichuan University, Chengdu, Sichuan, China.
Wang J; Department of Urology/Institute of Urology, West China Hospital, Sichuan University, Chengdu, Sichuan, China.
Tang Y; Department of Urology/Institute of Urology, West China Hospital, Sichuan University, Chengdu, Sichuan, China. Electronic address: .
Han P; Department of Urology/Institute of Urology, West China Hospital, Sichuan University, Chengdu, Sichuan, China. Electronic address: .
Bai Y; Department of Urology/Institute of Urology, West China Hospital, Sichuan University, Chengdu, Sichuan, China. Electronic address: .; Pokaż więcej
Źródło:: Life sciences [Life Sci] 2024 Oct 15; Vol. 355, pp. 122974. Date of Electronic Publication: 2024 Aug 13.
Typ publikacji:: Journal Article
MeSH Terms:: Urinary Bladder Neoplasms*/pathology
Urinary Bladder Neoplasms*/metabolism
Urinary Bladder Neoplasms*/genetics
Phosphopyruvate Hydratase*/metabolism
Phosphopyruvate Hydratase*/genetics
Glycolysis*
Tumor Suppressor Proteins*/metabolism
Tumor Suppressor Proteins*/genetics
ARNTL Transcription Factors*/metabolism
ARNTL Transcription Factors*/genetics
Cell Proliferation*
DNA-Binding Proteins*/metabolism
DNA-Binding Proteins*/genetics
Humans ; Animals ; Mice ; Cell Line, Tumor ; Disease Progression ; Mice, Nude ; Apoptosis ; Female ; Gene Expression Regulation, Neoplastic ; Male ; Mice, Inbred BALB C ; Carcinogenesis/metabolism ; Carcinogenesis/genetics ; Biomarkers, Tumor

Czasopismo naukowe

na półce

Full Text Finder Szczegóły

Skocz do pozycji: 11.

Tytuł:: Comment to "An unusual "linitis plastica" like breast cancer bladder metastasis".
Autorzy:: Diaz R; Department of Surgical and Diagnostic Integrated Sciences (DISC), University of Genoa; IRCCS Ospedale Policlinico San Martino, Genoa. .
Leonardi R; Casa di Cura Musumeci GECAS, Gravina di Catania (CT). .
Murelli F; Department of Surgical and Diagnostic Integrated Sciences (DISC), University of Genoa; IRCCS Ospedale Policlinico San Martino, Genoa. .
Fregatti P; Department of Surgical and Diagnostic Integrated Sciences (DISC), University of Genoa; IRCCS Ospedale Policlinico San Martino, Genoa. .
Terrone C; Department of Surgical and Diagnostic Integrated Sciences (DISC), University of Genoa; IRCCS Ospedale Policlinico San Martino, Genoa. .
Mantica G; Department of Surgical and Diagnostic Integrated Sciences (DISC), University of Genoa; IRCCS Ospedale Policlinico San Martino, Genoa. .; Pokaż więcej
Źródło:: Archivio italiano di urologia, andrologia : organo ufficiale [di] Societa italiana di ecografia urologica e nefrologica [Arch Ital Urol Androl] 2024 Oct 02; Vol. 96 (3), pp. 12784. Date of Electronic Publication: 2024 Oct 02.
Typ publikacji:: Letter; Comment; Journal Article
MeSH Terms:: Urinary Bladder Neoplasms*/pathology
Urinary Bladder Neoplasms*/secondary
Breast Neoplasms*/pathology
Linitis Plastica*/secondary
Linitis Plastica*/pathology
Humans ; Female

Czasopismo naukowe

na półce

Full Text Finder Szczegóły

Skocz do pozycji: 12.

Tytuł:: Integrin α6-containing extracellular vesicles promote lymphatic remodelling for pre-metastatic niche formation in lymph nodes via interplay with CD151.
Autorzy:: Lin Y; Department of Urology, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, Guangdong, P. R. China.; Guangdong Provincial Key Laboratory of Malignant Tumor Epigenetics and Gene Regulation, Sun Yat-sen Memorial Hospital, State Key Laboratory of Oncology in South China, Guangzhou, Guangdong, P. R. China.
Zheng H; Department of Urology, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, Guangdong, P. R. China.; Guangdong Provincial Key Laboratory of Malignant Tumor Epigenetics and Gene Regulation, Sun Yat-sen Memorial Hospital, State Key Laboratory of Oncology in South China, Guangzhou, Guangdong, P. R. China.
Jia L; Department of Nephrology, Xuanwu Hospital, Capital Medical University, Beijing, P. R. China.
Luo Y; Department of General Surgery, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, Guangzhou, Guangdong, P. R. China.
Zhang D; Department of General Surgery, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, Guangzhou, Guangdong, P. R. China.
An M; Department of Urology, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, Guangdong, P. R. China.; Guangdong Provincial Key Laboratory of Malignant Tumor Epigenetics and Gene Regulation, Sun Yat-sen Memorial Hospital, State Key Laboratory of Oncology in South China, Guangzhou, Guangdong, P. R. China.
Pang M; Department of Urology, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, Guangdong, P. R. China.; Guangdong Provincial Key Laboratory of Malignant Tumor Epigenetics and Gene Regulation, Sun Yat-sen Memorial Hospital, State Key Laboratory of Oncology in South China, Guangzhou, Guangdong, P. R. China.
Diao X; Department of Thoracic Surgery, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
Li W; Department of Urology, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, Guangdong, P. R. China.; Guangdong Provincial Key Laboratory of Malignant Tumor Epigenetics and Gene Regulation, Sun Yat-sen Memorial Hospital, State Key Laboratory of Oncology in South China, Guangzhou, Guangdong, P. R. China.
Chen J; Department of Urology, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, Guangdong, P. R. China.; Guangdong Provincial Key Laboratory of Malignant Tumor Epigenetics and Gene Regulation, Sun Yat-sen Memorial Hospital, State Key Laboratory of Oncology in South China, Guangzhou, Guangdong, P. R. China.
Li Y; Department of Urology, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, Guangdong, P. R. China.; Guangdong Provincial Key Laboratory of Malignant Tumor Epigenetics and Gene Regulation, Sun Yat-sen Memorial Hospital, State Key Laboratory of Oncology in South China, Guangzhou, Guangdong, P. R. China.
Liu D; Department of Urology, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, Guangdong, P. R. China.; Guangdong Provincial Key Laboratory of Malignant Tumor Epigenetics and Gene Regulation, Sun Yat-sen Memorial Hospital, State Key Laboratory of Oncology in South China, Guangzhou, Guangdong, P. R. China.
Liu Z; Department of Urology, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, Guangdong, P. R. China.; Guangdong Provincial Key Laboratory of Malignant Tumor Epigenetics and Gene Regulation, Sun Yat-sen Memorial Hospital, State Key Laboratory of Oncology in South China, Guangzhou, Guangdong, P. R. China.
Huang J; Department of Urology, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, Guangdong, P. R. China.; Guangdong Provincial Key Laboratory of Malignant Tumor Epigenetics and Gene Regulation, Sun Yat-sen Memorial Hospital, State Key Laboratory of Oncology in South China, Guangzhou, Guangdong, P. R. China.
Lin T; Department of Urology, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, Guangdong, P. R. China.; Guangdong Provincial Key Laboratory of Malignant Tumor Epigenetics and Gene Regulation, Sun Yat-sen Memorial Hospital, State Key Laboratory of Oncology in South China, Guangzhou, Guangdong, P. R. China.; Department of Urology, The Fifth Affiliated Hospital of Sun Yat-sen University, Zhuhai, Guangdong, P. R. China.
Chen C; Department of Urology, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, Guangdong, P. R. China.; Guangdong Provincial Key Laboratory of Malignant Tumor Epigenetics and Gene Regulation, Sun Yat-sen Memorial Hospital, State Key Laboratory of Oncology in South China, Guangzhou, Guangdong, P. R. China.; Pokaż więcej
Źródło:: Journal of extracellular vesicles [J Extracell Vesicles] 2024 Oct; Vol. 13 (10), pp. e12518.
Typ publikacji:: Journal Article
MeSH Terms:: Extracellular Vesicles*/metabolism
Integrin alpha6*/metabolism
Tetraspanin 24*/metabolism
Lymph Nodes*/metabolism
Lymph Nodes*/pathology
Lymphatic Metastasis*
Urinary Bladder Neoplasms*/pathology
Urinary Bladder Neoplasms*/metabolism
Humans ; Animals ; Mice ; Cell Line, Tumor ; Female ; Male ; Lymphangiogenesis ; Endothelial Cells/metabolism ; E-Selectin/metabolism

Czasopismo naukowe

na półce

Full Text Finder Szczegóły

Skocz do pozycji: 13.

Tytuł:: Comment on: A panel of four plasma amino acids is a promising biomarker for newly diagnosed bladder cancer.
Autorzy:: Ran L; Department of Urology, The Second Affiliated Hospital of Soochow University, Suzhou, Jiangsu 215004, China; Department of Urology, Peking University First Hospital, Beijing, China; Institute of Urology, Peking University, Beijing, China; Department of Andrology, Peking University First Hospital, Beijing, China. Electronic address: .
Zhao Q; Department of Urology, Peking University First Hospital, Beijing, China; Institute of Urology, Peking University, Beijing, China; Department of Andrology, Peking University First Hospital, Beijing, China.
Zhao R; Acupuncture Center, Yueyang Hospital of Integrated Traditional Chinese and Western Medicine, Shanghai University of Traditional Chinese Medicine, Shanghai 200437, China.
Hu G; Department of Urology, The First People's Hospital of Hefei, Hefei, Anhui 230041, China.; Pokaż więcej
Źródło:: Clinical nutrition (Edinburgh, Scotland) [Clin Nutr] 2024 Oct; Vol. 43 (10), pp. 2346-2347. Date of Electronic Publication: 2024 Sep 06.
Typ publikacji:: Letter; Comment
MeSH Terms:: Urinary Bladder Neoplasms*/blood
Urinary Bladder Neoplasms*/diagnosis
Amino Acids*/blood
Biomarkers, Tumor*/blood
Humans

Opinia redakcyjna

na półce

Full Text Finder Szczegóły

Skocz do pozycji: 14.

Tytuł:: ASO Author Reflections: Temporal Trends in Urinary Diversion in Radical Cystectomies from Europe's Largest Monocentric Cohort with 2224 Cases Over 36 Years.
Autorzy:: Duwe G; Department of Urology and Pediatric Urology, University Medical Center of the Johannes Gutenberg-University Mainz, Mainz, Germany. .
Brandt MP; Department of Urology and Pediatric Urology, University Medical Center of the Johannes Gutenberg-University Mainz, Mainz, Germany.
Haferkamp A; Department of Urology and Pediatric Urology, University Medical Center of the Johannes Gutenberg-University Mainz, Mainz, Germany.; Pokaż więcej
Źródło:: Annals of surgical oncology [Ann Surg Oncol] 2024 Oct; Vol. 31 (10), pp. 7239-7240. Date of Electronic Publication: 2024 Jul 21.
Typ publikacji:: Journal Article
MeSH Terms:: Urinary Diversion*/methods
Cystectomy*/methods
Urinary Bladder Neoplasms*/surgery
Urinary Bladder Neoplasms*/pathology
Urinary Bladder Neoplasms*/epidemiology
Humans ; Europe/epidemiology ; Prognosis

Czasopismo naukowe

na półce

Full Text Finder Szczegóły

Skocz do pozycji: 15.

Tytuł:: Challenging the Paradigm of "BCG-unresponsive" Bladder Cancer: Does Additional Bacillus Calmette-Guérin Have an Effect?
Autorzy:: Myers AA; The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Tan WS; The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Grajales V; The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Hwang H; The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Bree KK; The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Navai N; The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Lee BH; The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Dinney CPN; The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Kamat AM; The University of Texas MD Anderson Cancer Center, Houston, TX, USA. Electronic address: .; Pokaż więcej
Źródło:: European urology [Eur Urol] 2024 Oct; Vol. 86 (4), pp. 366-368. Date of Electronic Publication: 2024 Jun 14.
Typ publikacji:: Letter; Editorial
MeSH Terms:: Urinary Bladder Neoplasms*/drug therapy
Urinary Bladder Neoplasms*/pathology
BCG Vaccine*/therapeutic use
Humans ; Adjuvants, Immunologic/therapeutic use ; Administration, Intravesical

Opinia redakcyjna

na półce

Full Text Finder Szczegóły

Skocz do pozycji: 16.

Tytuł:: Metastatic Pleomorphic Lobular Carcinoma of the Breast to the Urinary Bladder: A Report of 10 Cases and Assessment of TRPS1 in the Differential Diagnosis With Plasmacytoid Urothelial Carcinoma.
Autorzy:: Zhang GN; From the Departments of Pathology and Laboratory Medicine (Zhang, Susnik, Delma, Jorda, Kryvenko) and Radiation Oncology (Kryvenko), the Desai Sethi Urology Institute (Jorda, Kryvenko), and the Sylvester Comprehensive Cancer Center (Susnik, Jorda, Kryvenko), University of Miami Miller School of Medicine, Miami, Florida.
Susnik B; From the Departments of Pathology and Laboratory Medicine (Zhang, Susnik, Delma, Jorda, Kryvenko) and Radiation Oncology (Kryvenko), the Desai Sethi Urology Institute (Jorda, Kryvenko), and the Sylvester Comprehensive Cancer Center (Susnik, Jorda, Kryvenko), University of Miami Miller School of Medicine, Miami, Florida.
Paulsen EJ; the Department of Pathology, Virginia Piper Cancer Institute, Minneapolis, Minnesota (Paulsen, Lyons).
Lyons LL; the Department of Pathology, Virginia Piper Cancer Institute, Minneapolis, Minnesota (Paulsen, Lyons).
Delma KS; From the Departments of Pathology and Laboratory Medicine (Zhang, Susnik, Delma, Jorda, Kryvenko) and Radiation Oncology (Kryvenko), the Desai Sethi Urology Institute (Jorda, Kryvenko), and the Sylvester Comprehensive Cancer Center (Susnik, Jorda, Kryvenko), University of Miami Miller School of Medicine, Miami, Florida.
Jorda M; From the Departments of Pathology and Laboratory Medicine (Zhang, Susnik, Delma, Jorda, Kryvenko) and Radiation Oncology (Kryvenko), the Desai Sethi Urology Institute (Jorda, Kryvenko), and the Sylvester Comprehensive Cancer Center (Susnik, Jorda, Kryvenko), University of Miami Miller School of Medicine, Miami, Florida.
Epstein JI; the Departments of Pathology, Urology, and Oncology, The Johns Hopkins Medical Institutions, Baltimore, Maryland (Epstein).
Kryvenko ON; From the Departments of Pathology and Laboratory Medicine (Zhang, Susnik, Delma, Jorda, Kryvenko) and Radiation Oncology (Kryvenko), the Desai Sethi Urology Institute (Jorda, Kryvenko), and the Sylvester Comprehensive Cancer Center (Susnik, Jorda, Kryvenko), University of Miami Miller School of Medicine, Miami, Florida.; Pokaż więcej
Źródło:: Archives of pathology & laboratory medicine [Arch Pathol Lab Med] 2024 Oct 01; Vol. 148 (10), pp. 1110-1118.
Typ publikacji:: Journal Article
MeSH Terms:: Urinary Bladder Neoplasms*/diagnosis
Urinary Bladder Neoplasms*/pathology
Urinary Bladder Neoplasms*/metabolism
Breast Neoplasms*/pathology
Breast Neoplasms*/diagnosis
Breast Neoplasms*/metabolism
DNA-Binding Proteins*/metabolism
Biomarkers, Tumor*/metabolism
Biomarkers, Tumor*/analysis
Repressor Proteins*/metabolism
Carcinoma, Lobular*/secondary
Carcinoma, Lobular*/diagnosis
Carcinoma, Lobular*/metabolism
Carcinoma, Lobular*/pathology
Humans ; Female ; Diagnosis, Differential ; Aged ; Middle Aged ; Aged, 80 and over ; Immunohistochemistry ; GATA3 Transcription Factor/metabolism ; GATA3 Transcription Factor/analysis ; Transcription Factors/metabolism ; Carcinoma, Transitional Cell/diagnosis ; Carcinoma, Transitional Cell/metabolism ; Carcinoma, Transitional Cell/pathology ; Carcinoma, Transitional Cell/secondary ; Receptors, Estrogen/metabolism ; Receptors, Progesterone/metabolism

Czasopismo naukowe

na półce

Pełny tekst Szczegóły

Skocz do pozycji: 17.

Tytuł:: Editorial Comment on "Efficacy and safety of dose-dense gemcitabine plus cisplatin as neoadjuvant chemotherapy for muscle-invasive bladder cancer".
Autorzy:: Urabe F; Department of Urology, The Jikei University School of Medicine, Tokyo, Japan.
Suzuki H; Department of Urology, The Jikei University School of Medicine, Tokyo, Japan.
Iwatani K; Department of Urology, The Jikei University School of Medicine, Tokyo, Japan.; Department of Urology, Jikei University Kashiwa Hospital, Chiba, Japan.
Kimura T; Department of Urology, The Jikei University School of Medicine, Tokyo, Japan.; Pokaż więcej
Źródło:: International journal of urology : official journal of the Japanese Urological Association [Int J Urol] 2024 Oct; Vol. 31 (10), pp. 1107. Date of Electronic Publication: 2024 Jul 16.
Typ publikacji:: Editorial; Journal Article
MeSH Terms:: Urinary Bladder Neoplasms*/drug therapy
Urinary Bladder Neoplasms*/pathology
Gemcitabine*
Deoxycytidine*/analogs & derivatives
Deoxycytidine*/administration & dosage
Deoxycytidine*/adverse effects
Cisplatin*/administration & dosage
Cisplatin*/adverse effects
Neoadjuvant Therapy*/adverse effects
Neoadjuvant Therapy*/methods
Antineoplastic Combined Chemotherapy Protocols*/adverse effects
Antineoplastic Combined Chemotherapy Protocols*/therapeutic use
Antineoplastic Combined Chemotherapy Protocols*/administration & dosage
Humans ; Neoplasm Invasiveness/pathology ; Cystectomy ; Treatment Outcome

Czasopismo naukowe

na półce

Full Text Finder Szczegóły

Skocz do pozycji: 18.

Tytuł:: Association of Age with Non-muscle-invasive Bladder Cancer: Unearthing a Biological Basis for Epidemiological Disparities?
Autorzy:: Lobo N; Department of Urology, Royal Free London NHS Trust, London, UK; Department of Urology, University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Duan Z; Department of Health Services Research, University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Sood A; Department of Urology, University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Tan WS; Department of Urology, University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Grajales V; Department of Urology, University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Contieri R; Department of Urology, University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Lindskrog SV; Department of Molecular Medicine, Aarhus University Hospital, Aarhus, Denmark; Department of Clinical Medicine, Aarhus University, Aarhus, Denmark.
Dyrskjøt L; Department of Molecular Medicine, Aarhus University Hospital, Aarhus, Denmark; Department of Clinical Medicine, Aarhus University, Aarhus, Denmark.
Zhao H; Department of Health Services Research, University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Giordano SH; Department of Health Services Research, University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Williams SB; Department of Urology, University of Texas Medical Branch, Galveston, TX, USA.
Bree KK; Department of Urology, University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Kamat AM; Department of Urology, University of Texas MD Anderson Cancer Center, Houston, TX, USA. Electronic address: .; Pokaż więcej
Źródło:: European urology oncology [Eur Urol Oncol] 2024 Oct; Vol. 7 (5), pp. 1069-1079. Date of Electronic Publication: 2024 Feb 01.
Typ publikacji:: Journal Article
MeSH Terms:: Urinary Bladder Neoplasms*/pathology
Urinary Bladder Neoplasms*/mortality
Urinary Bladder Neoplasms*/epidemiology
Humans ; Aged ; Female ; Male ; Aged, 80 and over ; Age Factors ; Neoplasm Invasiveness ; SEER Program ; United States/epidemiology ; Medicare/statistics & numerical data ; Non-Muscle Invasive Bladder Neoplasms

Czasopismo naukowe

na półce

Full Text Finder Szczegóły

Skocz do pozycji: 19.

Tytuł:: Cost-effectiveness analysis of different treatment modalities in BCG-unresponsive NMIBC.
Autorzy:: Rieger C; Department of Urology, Urologic Oncology, Robot-Assisted and Specialized Urologic Surgery, University of Cologne, Cologne, Germany.
Schlüchtermann J; Faculty of Law, Business and Economics, University of Bayreuth, Bayreuth, Germany.
Storz E; Department of Urology, Urologic Oncology, Robot-Assisted and Specialized Urologic Surgery, University of Cologne, Cologne, Germany.
Kastner L; Department of Urology, Urologic Oncology, Robot-Assisted and Specialized Urologic Surgery, University of Cologne, Cologne, Germany.
Pfister D; Department of Urology, Urologic Oncology, Robot-Assisted and Specialized Urologic Surgery, University of Cologne, Cologne, Germany.
Heidenreich A; Department of Urology, Urologic Oncology, Robot-Assisted and Specialized Urologic Surgery, University of Cologne, Cologne, Germany.; Department of Urology, Medical University Vienna, Vienna, Austria.; Pokaż więcej
Źródło:: BJU international [BJU Int] 2024 Oct; Vol. 134 (4), pp. 582-588. Date of Electronic Publication: 2024 Mar 16.
Typ publikacji:: Journal Article
MeSH Terms:: Cost-Benefit Analysis*
Urinary Bladder Neoplasms*/drug therapy
Urinary Bladder Neoplasms*/economics
Gemcitabine*
Deoxycytidine*/analogs & derivatives
Deoxycytidine*/economics
Deoxycytidine*/therapeutic use
Humans ; BCG Vaccine/economics ; BCG Vaccine/therapeutic use ; Docetaxel/therapeutic use ; Docetaxel/economics ; Antibodies, Monoclonal, Humanized/therapeutic use ; Antibodies, Monoclonal, Humanized/economics ; Quality-Adjusted Life Years ; Male ; Administration, Intravesical ; Salvage Therapy/economics ; Cystectomy/economics ; Female ; Carcinoma, Transitional Cell/drug therapy ; Carcinoma, Transitional Cell/economics ; Hyperthermia, Induced/economics ; Antineoplastic Combined Chemotherapy Protocols/economics ; Antineoplastic Combined Chemotherapy Protocols/therapeutic use ; Markov Chains ; Aged ; Middle Aged ; Cost-Effectiveness Analysis ; Non-Muscle Invasive Bladder Neoplasms

Czasopismo naukowe

na półce

Full Text Finder Szczegóły

Skocz do pozycji: 20.

Tytuł:: Prognostic Value of NLR, PLR, SII, and dNLR in Urothelial Bladder Cancer Following Radical Cystectomy.
Autorzy:: Salari A; Uro-Oncology Research Center, Tehran University of Medical Sciences, Tehran, Iran.
Ghahari M; Uro-Oncology Research Center, Tehran University of Medical Sciences, Tehran, Iran.
Bitaraf M; Uro-Oncology Research Center, Tehran University of Medical Sciences, Tehran, Iran.
Fard ES; Uro-Oncology Research Center, Tehran University of Medical Sciences, Tehran, Iran.
Haddad M; Uro-Oncology Research Center, Tehran University of Medical Sciences, Tehran, Iran.
Momeni SA; Uro-Oncology Research Center, Tehran University of Medical Sciences, Tehran, Iran.
Inanloo SH; Uro-Oncology Research Center, Tehran University of Medical Sciences, Tehran, Iran.
Ghahari P; Uro-Oncology Research Center, Tehran University of Medical Sciences, Tehran, Iran.
Mohamoud MM; Uro-Oncology Research Center, Tehran University of Medical Sciences, Tehran, Iran.
Mohamadzadeh M; Uro-Oncology Research Center, Tehran University of Medical Sciences, Tehran, Iran.
Nowroozi MR; Uro-Oncology Research Center, Tehran University of Medical Sciences, Tehran, Iran.
Amini E; Uro-Oncology Research Center, Tehran University of Medical Sciences, Tehran, Iran. Electronic address: .; Pokaż więcej
Źródło:: Clinical genitourinary cancer [Clin Genitourin Cancer] 2024 Oct; Vol. 22 (5), pp. 102144. Date of Electronic Publication: 2024 Jun 22.
Typ publikacji:: Journal Article
MeSH Terms:: Urinary Bladder Neoplasms*/surgery
Urinary Bladder Neoplasms*/blood
Urinary Bladder Neoplasms*/mortality
Urinary Bladder Neoplasms*/pathology
Cystectomy*
Neutrophils*
Lymphocytes*/pathology
Humans ; Male ; Female ; Aged ; Prognosis ; Retrospective Studies ; Middle Aged ; Blood Platelets/pathology ; Lymphocyte Count ; Platelet Count ; Neoadjuvant Therapy ; Kaplan-Meier Estimate ; Aged, 80 and over ; Inflammation/blood ; Survival Analysis

Czasopismo naukowe

na półce

Full Text Finder Szczegóły

Informacja

Wyszukujesz frazę ""Urinary Bladder Neoplasms"" wg kryterium: Temat